Financial Performance - Revenue for the six months ended June 30, 2022, was HKD 1,963,837,000, an increase of 10.5% compared to HKD 1,776,676,000 in the same period of 2021[15] - Gross profit for the same period was HKD 583,618,000, up from HKD 528,380,000, reflecting a gross margin improvement[15] - Profit before tax increased slightly to HKD 412,139,000 from HKD 409,816,000, indicating stable operational performance[15] - Net profit attributable to shareholders for the period was HKD 272,476,000, compared to HKD 263,904,000 in the previous year, representing a growth of 3.5%[20] - Basic earnings per share for the ongoing operations was HKD 25.40, an increase from HKD 24.60 in the prior year[20] - The company reported a period profit of HKD 371,944,000 for 2022, an increase of 15.8% compared to HKD 321,024,000 in 2021[23] - The total comprehensive income for the period was a loss of HKD 713,201,000, compared to a gain of HKD 359,634,000 in the previous year[23] - The fair value change of equity instruments through other comprehensive income resulted in a loss of HKD 400,033,000, significantly higher than the loss of HKD 62,711,000 in 2021[23] Operating Expenses and Income - The company reported a significant increase in other income to HKD 198,866,000 from HKD 141,859,000, marking a growth of 40%[15] - Total operating expenses decreased to HKD 520,973,000 from HKD 566,028,000, showing a reduction of approximately 8%[15] - The company reported a significant reduction in financial expenses, which were recorded at HKD 7,797,000, down from previous levels, contributing to improved net profitability[68] Assets and Liabilities - The company's total assets decreased to HKD 22,694,823,000 from HKD 23,457,987,000, reflecting a decline of approximately 3.2%[26] - Current assets amounted to HKD 10,676,665,000, slightly down from HKD 10,752,276,000 in the previous year[26] - Total liabilities increased to HKD 5,628,579,000 from HKD 5,582,329,000, indicating a rise of approximately 0.8%[29] - The equity attributable to the company's owners decreased to HKD 12,455,784,000 from HKD 12,898,693,000, a decline of about 3.4%[29] Cash Flow - The net cash generated from operating activities for the six months ended June 30, 2022, was HKD 295,748, compared to a net cash used of HKD (104,717) in the same period of 2021[34] - The net cash generated from investing activities was HKD 562,203, an improvement from a net cash used of HKD (698,433) in the prior year[34] - The total cash and cash equivalents increased to HKD 4,594,562 as of June 30, 2022, up from HKD 3,427,477 a year earlier[34] - The company reported a significant increase in cash and cash equivalents, with a net increase of HKD 759,510 compared to a decrease of HKD (899,772) in the previous year[34] Segment Performance - Revenue from public utilities reached HKD 954,703, while revenue from pharmaceuticals was HKD 819,441 for the six months ended June 30, 2022[53] - The hotel segment generated revenue of HKD 40,337, and the electromechanical segment contributed HKD 149,356 during the same period[53] - The pharmaceutical segment reported revenue of approximately HKD 819,400,000, an increase of 5.2% compared to HKD 779,000,000 in the same period last year[169] - The revenue from pharmaceutical product sales was approximately HKD 737,000,000, up 5.5% from HKD 698,400,000 year-on-year[169] Future Strategies - Future strategies include potential market expansion and investment in new technologies to enhance operational efficiency and service delivery[8] - The company plans to continue expanding its market presence and investing in new technologies to enhance operational efficiency and service delivery[60] Shareholder Information - The major shareholder, Tianjin TEDA Investment Holding Co., Ltd., held 62.81% of the issued shares as of June 30, 2022[195] - The interim dividend declared for the six months ended June 30, 2022, is HKD 3.45 per share, totaling approximately HKD 37,011,000, consistent with the previous year's interim dividend[104] Compliance and Governance - The company complied with the corporate governance code as per the Stock Exchange Listing Rules, except for the absence of the chairman at the annual general meeting[198] Employee Information - The group employed approximately 2,531 employees, including 213 management personnel and 781 technical staff during the review period[188]
天津发展(00882) - 2022 - 中期财报